Clinical Trials Directory

Trials / Unknown

UnknownNCT04917289

CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients

Circulating Tumor Cell vs. Radiography as the Evidence of Disease Recurrence in Colorectal Cancer Patients Whose Tumor Underwent R0 Resection

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Fudan University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study enrolled patients who underwent R0 resection of tumor and had elevated tumor biomarkers (CEA, CA19-9). After enroll the study, a CTC test will performed and patients who had positive CTC will be randomly assigned to two groups. The control group will continue follow-up until radiological recurrence appear, the treatment group will start treatment or change the current adjuvant regimen. First endpoint is OS. The secondary endpoint is DFS, adverse event.

Conditions

Interventions

TypeNameDescription
DRUGChemotherapyStarted chemotherapy or change the current adjuvant therapy

Timeline

Start date
2021-06-01
Primary completion
2023-12-01
Completion
2025-12-01
First posted
2021-06-08
Last updated
2021-06-08

Source: ClinicalTrials.gov record NCT04917289. Inclusion in this directory is not an endorsement.

CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients (NCT04917289) · Clinical Trials Directory